Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen

Authors:

Abstract
Objective: The objective of this study was to determine the prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) in young compared with older adults.Methods: Individuals (n = 1420) with (63%) and without type 2 diabetes mellitus (T2D; 37%) who attended internal medicine clinics and did not have a known history of MASLD underwent laboratory evaluation and transient elastography to assess for hepatic steatosis and fibrosis. Magnetic resonance elastography and liver biopsy were recommended when indicated.Results: A total of 243 participants were ages p < 0.01). In young adults, T2D and obesity were the strongest risk factors for hepatic fibrosis (odds ratios 4.33 [95% CI: 1.37–13.68] and 1.16 [95% CI: 1.07–1.25], respectively; p < 0.05).Conclusions: There is a high prevalence of clinically significant hepatic fibrosis in young adults with cardiometabolic risk factors. Up to one in seven young adults with obesity and T2D had clinically significant hepatic fibrosis on elastography. This highlights the need to screen young adults with cardiometabolic risk factors for MASLD for early detection and intervention.
Funding Information
  • National Institutes of Health (DK‐120331)
  • Echosens

This publication has 44 references indexed in Scilit: